Fresh Tracks Correlations
| FRTXDelisted Stock | USD 0.78 0.09 10.34% |
The current 90-days correlation between Fresh Tracks Therapeutics and Assembly Biosciences is -0.13 (i.e., Good diversification). The correlation of Fresh Tracks is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Fresh Tracks Correlation With Market
Significant diversification
The correlation between Fresh Tracks Therapeutics and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Fresh Tracks Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Fresh |
The ability to find closely correlated positions to Fresh Tracks could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fresh Tracks when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fresh Tracks - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fresh Tracks Therapeutics to buy it.
Moving together with Fresh Pink Sheet
Moving against Fresh Pink Sheet
| 0.63 | SABSW | SAB Biotherapeutics | PairCorr |
| 0.57 | VCNX | Vaccinex | PairCorr |
| 0.5 | VERU | Veru Inc Fiscal Year End 13th of December 2024 | PairCorr |
| 0.48 | VERV | Verve Therapeutics | PairCorr |
| 0.39 | DRMA | Dermata Therapeutics | PairCorr |
| 0.85 | VRCA | Verrica Pharmaceuticals | PairCorr |
| 0.76 | VIRX | Viracta Therapeutics | PairCorr |
| 0.75 | EDIT | Editas Medicine | PairCorr |
| 0.62 | VNDA | Vanda Pharmaceuticals | PairCorr |
| 0.62 | CDTTW | Conduit Pharmaceuticals Symbol Change | PairCorr |
| 0.6 | SRZNW | Surrozen Warrant | PairCorr |
| 0.6 | VTVT | vTv Therapeutics | PairCorr |
| 0.59 | VIGL | Vigil Neuroscience | PairCorr |
| 0.59 | VIRI | Virios Therapeutics Llc | PairCorr |
| 0.5 | VSTM | Verastem | PairCorr |
| 0.48 | VTGN | VistaGen Therapeutics | PairCorr |
| 0.47 | VTYX | Ventyx Biosciences | PairCorr |
| 0.43 | DYAI | Dyadic International | PairCorr |
| 0.41 | VRPX | Virpax Pharmaceuticals | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Fresh Pink Sheet performing well and Fresh Tracks Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Fresh Tracks' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ASMB | 2.73 | 0.29 | 0.10 | 0.31 | 3.24 | 6.02 | 20.11 | |||
| TIL | 8.21 | 3.34 | 0.65 | 0.97 | 4.09 | 31.13 | 105.83 | |||
| NUVB | 3.12 | (0.15) | (0.03) | 0.01 | 3.65 | 6.98 | 17.51 | |||
| ACHL | 2.36 | 0.12 | 0.07 | 0.19 | 1.95 | 3.75 | 9.00 | |||
| NXTC | 2.64 | (0.04) | 0.00 | 0.09 | 3.12 | 4.67 | 20.01 | |||
| CMRA | 5.99 | (0.10) | 0.00 | (0.02) | 0.00 | 13.95 | 30.28 | |||
| SABS | 4.13 | 0.45 | 0.10 | 0.57 | 4.16 | 11.50 | 24.64 | |||
| PCSA | 3.80 | (0.44) | 0.00 | (0.23) | 0.00 | 7.69 | 42.29 | |||
| THRD | 2.63 | 0.20 | 0.08 | 0.27 | 2.56 | 5.88 | 16.60 | |||
| UNCY | 5.82 | (0.35) | 0.00 | (0.07) | 0.00 | 10.26 | 51.36 |
View Fresh Tracks Related Equities
| Risk & Return | Correlation |
Fresh Tracks Corporate Management
| Albert II | CFO Officer | Profile | |
| Andrew Sklawer | Pres CoFounder | Profile | |
| Nancy Seretta | VP Operations | Profile | |
| PM MBA | VP Operations | Profile | |
| Gary Walker | Chief Officer | Profile | |
| Attorney Brown | CEO Director | Profile | |
| David JD | G Officer | Profile |
Still Interested in Fresh Tracks Therapeutics?
Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.